Dutch pharmaceutical company Novo Nordisk has announced plans to sell authorised generics of its insulin drug Novolog at a reduced price in the US.
The generic products will be available through the company’s US affiliate Novo Nordisk Pharma at 50% less than the list price of the existing branded versions.
